Tenders Are Invited For Advantageous s For the purchase of MAT Consumption, MAT and Veterinary, Pharmacologi ... in Brazil

Work Detail

1 ESCINASCINA, amorphous presentation, associated with sodic polysulfoned scru, diethylamine salicylate composition, 10mg 10mg 50mgg concentration, application GEL Differentiated Typicotreatment: Type I EXCLUSIVE MEEPP ParticipationEquipped Applicaility Decree 7174: Non APPLICAILITY Preference margin: Non Quantity: 20 Supply Unit: Tue 3000 G2 FentanilaFentanil, Presentation Citrate Salt, Dosage 005 mgml, Indication Injectale Solution Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non Quantity: 300 Supply Unit: Ampoule 200 ML3 Toramicinatoramicin, Dosage 03, presentation Ophthalmic Solution Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference Margin: Non QUANTITY: 75 500 ml4 activated activated activated coal , Composition associated with zeolite, caoim and pectin, concentration40 40 10 10, physical forms oral powder, use veterinariotraising differentiated: Type I exclusive participation of MEEPPEquipped Applicaility Decree 7174: non applicaility Preference margin: non quantity: 100 supply unit: Sachet 800 G5 Sulfatooamica Sulfate Sulfatoamicin, dosage 250 mgml, Indication Injectale Solution Differentiated Treatment: Type I Exclusive Participation of MEEPPEquipped Applicaility Decree 7174: Non Applicaility Preference: Non Quantity: 150 Supply Unit: Ampoule 200 Ml

Contact Information